Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

354
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
354
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
Structure and Function of Platelets01:18

Structure and Function of Platelets

2.8K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

355
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
355

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Initiation of an emergency department discharge pathway for low-risk patients with venous thromboembolism: Factors impact real-world practice.

Vascular medicine (London, England)·2026
Same author

Cumulative Metabolic Exposure to Hyperglycemia and Risk of Cardiovascular and Limb Events in Peripheral Artery Disease.

medRxiv : the preprint server for health sciences·2026
Same author

Variability in Cardiac Stress Test Interpretation: Agreement Between Enrollment Sites and Core Laboratories in the Global ISCHEMIA Trial.

Circulation. Population health and outcomes·2026
Same author

Whole blood epigenomic and transcriptomic characterization identifies vulnerable molecular subtypes of chronic coronary disease.

Nature communications·2026
Same author

ERBB4 deficiency promotes atrial myopathy underlying the atrial fibrillation substrate.

medRxiv : the preprint server for health sciences·2026
Same author

Validation of Brachial Vein Endothelial Transcriptomics to Assess the Coronary Vasculature.

Circulation research·2026

相关实验视频

Updated: Jan 11, 2026

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
07:14

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation

Published on: July 13, 2018

15.1K

血小板诱导内皮细胞线粒体功能障碍在心肌梗塞的心肌梗塞.

Haoyu Sun1, Florencia Schlamp1, Matthew Muller1,2

  • 1Leon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.

Science advances
|November 14, 2025
PubMed
概括

来自心肌梗塞 (MI) 患者的血小板会导致内皮线粒体功能障碍. 由这些血小板释放的C-C动机化学因子联体3 (CCL3) 是一个关键的调解者,将血小板激活与冠状动脉内皮功能障碍联系起来.

更多相关视频

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
06:04

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

11.7K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

989

相关实验视频

Last Updated: Jan 11, 2026

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
07:14

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation

Published on: July 13, 2018

15.1K
LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
06:04

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

11.7K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

989

科学领域:

  • 心血管生物学 心血管生物学
  • 线粒体医学 线粒体医学
  • 血小板生理学 血小板生理学

背景情况:

  • 冠状动脉内皮功能障碍是急性冠状动脉综合征的核心.
  • 心肌梗塞 (MI) 中的血小板释放出导致血管损伤的因素.
  • 了解血小板-内皮相互作用对于治疗心血管疾病至关重要.

研究的目的:

  • 调查血小板释放因子在心脏病发作后内皮功能障碍中的作用.
  • 为了确定参与血小板诱导的内皮线粒体损伤的特定媒介.
  • 探索心血管疾病中确定的调解者的临床相关性.

主要方法:

  • 内皮细胞 (ECs) 用来自心脏病发作患者血小板的因子进行治疗.
  • 进行了RNA测序和线粒体功能测定 (膜潜力,网络分析).
  • 在患有心血管疾病的患者中测量了循环C-C动机化学因配体3 (CCL3) 水平.

主要成果:

  • MI血小板诱导了显著的EC线粒体功能障碍.
  • 鉴定出C-C动机化学基因连接体3 (CCL3) 是一个关键的调解者,在MI血小板上升调节.
  • 阻断CCL3受体,CCR5,可以减少它对ECs的有害影响.
  • 在患者中,循环中CCL3水平升高与主要心血管不良事件相关.

结论:

  • 血小板激活在MI中直接导致冠状动脉内皮线粒体功能障碍.
  • CCL3是一个关键的调解者,将MI血小板与内皮损伤联系起来.
  • CCL3可以作为心血管事件的生物标志物和治疗点.